Our Mission
Replacing episodic guesswork with continuous intelligence.
Bone disease affects over 700 million people globally, yet the standard of care relies on looking backwards. A DEXA scan tells you bone density loss after years of irreversible damage. Blood panels provide a multi-month snapshot. Neither provides the resolution needed to actually intercept disease.
We're building the infrastructure for a world where bone turnover is tracked in real-time. By coupling painless microneedle biosensors with time-series machine learning, Osteon provides the first dynamic view into the skeletal system — enabling physicians to predict fractures, forecast flare-ups, and validate treatments within weeks instead of years.
Team
Founded at Harvard.
Zinia Khattar
CEO & Co-Founder • Harvard University '29
Zinia is a nationally recognized biomedical researcher whose deep life sciences expertise drives Osteon's clinical vision, regulatory strategy, and commercial growth.
Yashvir Sabharwal
CTO & Co-Founder • Harvard University '29
Yashvir is a published machine learning researcher who architectures Osteon's hardware integration and proprietary time-series AI models to translate biochemical data into clinical insights.
Roadmap
Bone today. Every tissue tomorrow.
Osteoporosis & OA
Launching the first continuous ISF monitoring platform for bone turnover markers, targeting high-risk osteoporotic patients and OA therapeutic monitoring. Replacing the static FRAX model with dynamic forecasting.
- Pivotal clinical validation
- FDA Breakthrough Device
- Initial commercial rollout
Renal & Metabolic
Expanding biomarker multiplexing to capture the full CKD-MBD panel, providing nephrologists with real-time feedback on phosphate binders and calcimimetics before systemic damage occurs.
- CKD-MBD panel launch
- Hemodialysis integration
- Predictive complications AI
Oncology & Beyond
Establishing Osteon as the universal platform for continuous protein and ion telemetry, beginning with oncology bone metastasis monitoring and expanding to systemic inflammation.
- Tumor marker tracking
- Systemic inflammatory telemetry
- Global health deployment
Get early access to the future of bone health.
Join the waitlist and be the first to know when Osteon launches. No spam — we respect your inbox.